Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.
about
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in micePneumococcal capsular polysaccharide structure predicts serotype prevalenceAntimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F Pneumococci in northern Thailand.Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.Characterization of the cross-reaction between type 19F(19) and 19A(57) pneumococcal capsular polysaccharides: compositional analysis and immunological relation determined with rabbit typing antiseraPrevention of pneumococcal infection in children with homozygous sickle cell diseasePreparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.Pneumococcal vaccination and revaccination of older adults.Extra-immunization as a clinical indicator for fragmentation of careImmunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands.Immunizations in the elderly.Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.Anti-pneumococcal antibody titre measurement: what useful information does it yield?Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.Natural killer cell regulation of age-related and type-specific variations in antibody responses to pneumococcal polysaccharides.Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine.Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complexFurther studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugatesEnzyme immunoassay for detection of immunoglobulin G (IgG), IgM, and IgA antibodies against type 6B pneumococcal capsular polysaccharide and cell wall C polysaccharide in chinchilla serumSafety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children.Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F.Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine.Vaccination against pneumococcal disease.
P2860
Q28346515-76CBAD06-6EE4-4925-8A7D-F414B7A61ACAQ28475595-A2D3C064-335C-4A8E-ABD4-6F44188657ABQ30333415-F95AE1DF-1207-46E3-8D2A-3B31437024AFQ33754233-EBF7F5AA-5A00-46C1-8903-85A3287150E9Q33788106-BA25CAA7-90DF-46E7-8CFF-964F882ED288Q34462387-C6CC20BE-CB38-421C-881D-DB0254B4B9F9Q34548579-E650ECE7-EABA-43B4-A063-EA3BAF5EA2C2Q34714055-900E9A30-26DA-47A0-9508-96857DA365D2Q34926870-6D67D0CC-5878-4B98-8794-2D9F2D32CAC9Q35040464-4E8E0339-5F67-45D1-A739-3FA4ACA6C2E3Q35115490-E5011007-6109-4685-88B4-1E21EF9052CAQ35119865-DA33AAD1-086F-4D90-8C62-18B7A9B8C2B0Q35231638-57757915-16C7-4C14-B8AB-D6A1AB6F219DQ35533941-BACBB8CF-ED2C-479F-8964-8B82CFCE387BQ36026175-2F7B3F89-A6A8-42F3-9E60-BBA18EB4A878Q36344138-5F2C7284-6811-4032-AE36-699CAB0114E7Q36353060-2D8AD206-7A66-472C-9BFF-D4AC42275C1CQ36731011-3614ACE9-BA9A-40F3-8063-C0B890C0E2EDQ36972189-41C98BE6-C5F5-4E81-8E73-685710A18702Q37110954-714B5E08-3A50-4BEC-A811-44B95CF561A7Q37121761-D0893202-A037-46CF-84CB-CB04BF5AB2BDQ37544974-0462C0BC-FF0E-4FDE-90BB-48FB407A197FQ39077664-B66123B1-72E4-4EB1-8C28-7977C11E31CAQ39831746-5EFF7E69-0950-4831-9DA8-11BF4F0413A3Q39860192-1AE97C61-1AB6-498C-B06A-8FF61EAC7DEAQ40056277-4BAC540E-0BC6-4E7F-B0DD-968F7022AB83Q40269965-57B2A529-1F87-4124-8D8C-6816B95699BDQ41838253-4FB27566-B85D-4EC7-B464-8A45A2EB3D6AQ43216658-47AA3778-6682-4EEE-B698-73F5D38394CE
P2860
Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Vaccination and revaccination ...... accines in adults and infants.
@en
Vaccination and revaccination ...... accines in adults and infants.
@nl
type
label
Vaccination and revaccination ...... accines in adults and infants.
@en
Vaccination and revaccination ...... accines in adults and infants.
@nl
prefLabel
Vaccination and revaccination ...... accines in adults and infants.
@en
Vaccination and revaccination ...... accines in adults and infants.
@nl
P2093
P1476
Vaccination and revaccination ...... accines in adults and infants.
@en
P2093
P304
P577
1978-01-01T00:00:00Z